Posts

Showing posts from February, 2023

CVS and Walmart cut pharmacy hours, close some locations earlier, citing staffing shortage - CNN

Image
New York CNN  —  An apparent shortage of pharmacists is forcing CVS and Walmart to reduce the hours of its pharmacies, as they close earlier in thousands of locations. Beginning in March, both retailers will either cut or shift the hours that their pharmacies operate in response to staffing shortages and waning consumer demand as the height of the Covid-19 pandemic recedes. The Wall Street Journal first reported the news. Walmart, which has pharmacies in most of its 4,600 US locations, will close them two hours earlier, at 7 pm. CVS will shift or cut hours at about 6,000 US pharmacies. For CVS, adjusting its hours is an attempt to ensure its "pharmacy teams are available to serve patients when they're most needed," the company said in a statement to CNN. The changes are part of its "regular course of business," it added, so its hours meet cus

Infuriating' Rx Denial Leaves Patient Without Antiemetics - Medscape

Image
It was Friday, and oncologist Coral Olazagasti, MD, faced a ticking clock. Her patient had taken his last prescription anti-nausea pill. Without a refill of ondansetron, he faced a long, painful weekend. The patient — a man with HPV-related oropharyngeal cancer — was experiencing severe side effects from standard chemoradiation with weekly cisplatin. Intense nausea and grade 3 mucositis, in particular, left him struggling to swallow or take in any food or fluids. He was on 8 mg of ondansetron (Zofran) every 8 hours, as needed, to keep the nausea at bay. The pills along with a feeding tube helped, but his symptoms were so intense, neither was quite enough. "He still needed to be hospitalized twice for dehydration," said Olazagasti, who specializes in head and neck medical cancer at Sylvester Comprehensive Cancer Center in Miami, Florida. But when it came t

Pseudoephedrine safety review due to rare brain risk - BBC

Image
Getty Images By Michelle Roberts Digital health editor Experts are assessing a very rare but potentially serious brain side effect of nasal decongestants bought on the High Street. Ones containing pseudoephedrine are being reviewed because they may cause vessels supplying the brain to contract or spasm, reducing blood flow. The concern is this could lead to seizures and even a stroke. However, drug regulators stress the likelihood of this happening is extremely low. Products already include warnings about the rare risks on patient information leaflets that come with the medicines, as well as more common side effects such as headache and dizziness. Experts say anyone with concerns about medication should speak to a doctor or pharmacist. All medicines can have some side effects. People take pseudoephedrine to relieve nasal congestion. It comes in sprays, liquids and tablets, and is sometimes mixed with other medicines for coughs and colds or allergies. What is pseudoephedrine and how doe

Antidiabetic Biguanides Market Current Status and Future Prospects ... - Trending in Pakistan

Image
New Jersey, United States,- Mr Accuracy Reports , Antidiabetic Biguanides market  report contains detailed information on factors influencing demand, growth, opportunities, challenges, and restraints. It provides detailed information about the structure and prospects for global and regional industries. In addition, the report includes data on research & development, new product launches, product responses from the global and local markets by leading players. The structured analysis offers a graphical representation and a diagrammatic breakdown of the Antidiabetic Biguanides  market  by region. The global market size of Antidiabetic Biguanides will reach (2028 Market size $$) million $ in 2032 with a CAGR of % from 2023-2032. Some of the Major Key players profiled in the study are  Pfizer, AstraZeneca, GlaxoSmithKline, Merck & Co, Eli Lilly, Sanofi, Takeda Pharmaceuticals, Novo Nordisk, Servier Laboratories, Boe

Colorado deputy shoots and kills man who popped an anti-anxiety pill - Boing Boing

Image
A disturbing video, taken on February 22, 2022, shows a Colorado sheriff's deputy in a confrontation with a man named Richard Ward, who was sitting in the backseat of his mother's parked car at a middle school in Pueblo. Ward expressed anxiety about the police, claiming they have mistreated him in the past. The deputy questions him about why he had been seen earlier trying to enter a car that wasn't his, to which Ward explains that he was at the school with his mother to pick up his little brother. He stepped out of his mother's car to take a brief walk and mistakenly thought another car in the lot belonged to his mother and tried to open the door. He told the deputy that he apologized to the woman in the car, and then found his mother's car. After the deputy asks Ward if he has any weapons, Ward takes out a pocket knife and places it on the car seat. Ward then puts a pill in his mouth. "What did you just stick in your mouth?" shouts the d

CMS Issues Proposed Guidance on Inflation Rebates Under ... - JD Supra

Image
On February 9, 2023, the Centers for Medicare & Medicaid Services (CMS) released initial program guidance on the inflation rebate provisions of the Inflation Reduction Act of 2022 (IRA). [1] These provisions apply to how Medicare Part B and Part D pay for the costs of drugs and biologics provided to Medicare beneficiaries. They require drug and biologics manufacturers to pay rebates to the Medicare program if their products' pricing increases at a rate that exceeds the pace of inflation. Comments are due to CMS by March 11, 2023 . [2] Key Takeaways — Medicare Part D How will CMS calculate the inflation rebate under Part D? The IRA requires drug manufacturers to pay annual rebates to CMS for drug prices that increase faster than the pace of inflation. Rebates will be calculated for each "applicable period," which is a 12-month window that runs from October 1 through September 30 of the following year. Manufacturers will be invoiced annually. The Par

Yaz (Drospirenone and Ethinyl Estradiol) Oral: Uses, Side Effects - Verywell Health

Image
What Is Yaz? Yaz ( drospirenone and ethinyl estradiol ) is a prescription medication for the prevention of pregnancy. Yaz is also a potential treatment option for acne and symptoms of premenstrual dysphoric disorder (PMDD) in people assigned female at birth who are at least 14 years old. As a combination birth control, Yaz contains human-made versions of naturally occurring sex hormones—estrogen and progesterone. Yaz works by influencing sex hormones. It is available by prescription in tablet form. Drospirenone and ethinyl estradiol are available under other brand names and as generic medications. Drug Facts Generic Name :   Drospirenone and ethinyl estradiol Brand Name(s) : Yaz, Gianvi, Loryna, Nikki, Ocella, Syeda, Vestura, Yasmin, Yaz 28, Zarah Drug Availability: Prescription Administration Route :   Oral Therapeutic Classification :   Monophasic contraceptive combination Available Generically : &n

Acetaminophen vs. Ibuprofen: Uses, Side Effects, and Safety - Verywell Health

Image
Two of the most common pain medications and fever reducers are acetaminophen and ibuprofen . Typically available over the counter, acetaminophen is sold in the United States as Tylenol, and is an ingredient in the products Excedrin and Nyquil. Ibuprofen is the active ingredient in Advil and Motrin, among others. These medications temporarily relieve pain due to headaches, muscle aches, toothaches, and the common cold, among other conditions. Still, there are some significant differences between acetaminophen and ibuprofen. This article provides an overview of how each drug works and compares what they do, their maximum dosages, safety information, and when you might choose one over the other.      Oleksandra Troian / Getty Images Ibuprofen Ibuprofen was developed in 1961 by a United Kingdom–based pharmacologist and researcher. It belongs to a class of medications known as nonsteroidal anti-inflammatory dru